A detailed history of Thrivent Financial For Lutherans transactions in Baxter International Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 365,175 shares of BAX stock, worth $14.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
365,175
Previous 360,787 1.22%
Holding current value
$14.4 Million
Previous $15.4 Million 20.78%
% of portfolio
0.02%
Previous 0.03%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$32.87 - $43.55 $144,233 - $191,097
4,388 Added 1.22%
365,175 $12.2 Million
Q1 2024

May 14, 2024

SELL
$37.88 - $43.77 $90,154 - $104,172
-2,380 Reduced 0.66%
360,787 $15.4 Million
Q4 2023

Feb 14, 2024

SELL
$31.71 - $38.95 $14.6 Million - $18 Million
-460,901 Reduced 55.93%
363,167 $14 Million
Q3 2023

Nov 14, 2023

SELL
$37.32 - $49.29 $2.49 Million - $3.29 Million
-66,771 Reduced 7.5%
824,068 $31.1 Million
Q2 2023

Aug 14, 2023

BUY
$39.98 - $47.68 $7.74 Million - $9.23 Million
193,650 Added 27.78%
890,839 $40.6 Million
Q1 2023

May 17, 2023

SELL
$37.58 - $52.57 $28.2 Million - $39.5 Million
-751,561 Reduced 51.88%
697,189 $28.3 Million
Q4 2022

Feb 08, 2023

BUY
$49.7 - $57.71 $22 Million - $25.6 Million
442,898 Added 44.03%
1,448,750 $73.8 Million
Q3 2022

Nov 14, 2022

SELL
$53.86 - $66.8 $19 Million - $23.6 Million
-353,424 Reduced 26.0%
1,005,852 $54.2 Million
Q2 2022

Aug 16, 2022

BUY
$63.83 - $80.0 $58.2 Million - $72.9 Million
911,691 Added 203.69%
1,359,276 $87.3 Million
Q1 2022

May 13, 2022

BUY
$76.85 - $89.45 $2.78 Million - $3.24 Million
36,196 Added 8.8%
447,585 $34.7 Million
Q4 2021

Feb 16, 2022

BUY
$74.57 - $87.19 $6.51 Million - $7.61 Million
87,234 Added 26.91%
411,389 $35.3 Million
Q3 2021

Nov 15, 2021

BUY
$73.77 - $83.61 $7.29 Million - $8.26 Million
98,814 Added 43.85%
324,155 $26.1 Million
Q2 2021

Aug 19, 2021

BUY
$80.5 - $88.01 $12.4 Million - $13.6 Million
154,098 Added 216.3%
225,341 $18.1 Million
Q1 2021

May 17, 2021

SELL
$76.38 - $86.03 $2.03 Million - $2.29 Million
-26,565 Reduced 27.16%
71,243 $6.01 Million
Q4 2020

Feb 16, 2021

SELL
$75.39 - $82.36 $5.81 Million - $6.35 Million
-77,066 Reduced 44.07%
97,808 $7.85 Million
Q3 2020

Nov 10, 2020

BUY
$78.33 - $90.73 $6.18 Million - $7.16 Million
78,868 Added 82.15%
174,874 $14.1 Million
Q2 2020

Aug 12, 2020

BUY
$78.66 - $94.14 $4,955 - $5,930
63 Added 0.07%
96,006 $8.25 Million
Q1 2020

May 15, 2020

SELL
$71.57 - $93.3 $264,594 - $344,930
-3,697 Reduced 3.71%
95,943 $7.79 Million
Q4 2019

Feb 13, 2020

SELL
$76.7 - $88.45 $9.54 Million - $11 Million
-124,423 Reduced 55.53%
99,640 $8.33 Million
Q3 2019

Nov 14, 2019

BUY
$81.4 - $89.78 $157,427 - $173,634
1,934 Added 0.87%
224,063 $19.6 Million
Q2 2019

Aug 13, 2019

SELL
$73.44 - $82.41 $10.8 Million - $12.1 Million
-147,153 Reduced 39.85%
222,129 $18.2 Million
Q1 2019

May 14, 2019

SELL
$64.48 - $81.31 $8.74 Million - $11 Million
-135,476 Reduced 26.84%
369,282 $30 Million
Q4 2018

Feb 15, 2019

BUY
$61.45 - $77.8 $1.67 Million - $2.12 Million
27,255 Added 5.71%
504,758 $33.3 Million
Q3 2018

Nov 15, 2018

BUY
$70.71 - $77.75 $32.1 Million - $35.3 Million
454,092 Added 1939.65%
477,503 $36.8 Million
Q2 2018

Aug 14, 2018

BUY
$63.43 - $75.41 $158,004 - $187,846
2,491 Added 11.91%
23,411 $1.73 Million
Q1 2018

May 08, 2018

BUY
$62.56 - $72.26 $40,476 - $46,752
647 Added 3.19%
20,920 $1.36 Million
Q4 2017

Feb 14, 2018

SELL
$61.45 - $66.05 $32,199 - $34,610
-524 Reduced 2.52%
20,273 $1.31 Million
Q3 2017

Nov 14, 2017

BUY
$59.5 - $64.61 $1.24 Million - $1.34 Million
20,797
20,797 $1.31 Million

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $19.8B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.